Here are five oral obesity candidates that, according to Mizuho’s Graig Suvannavejh, could change the weight loss game.

Americans are flocking to new weight loss medications like Novo Nordisk’s Wegovy and Eli Lilly's Zepbound, which work by ...

Orforglipron led to 11.5% placebo-adjusted weight loss at 72 weeks (among those who adhered to high-dose treatment) in Attain-1, versus 13.9% at 64 weeks in Oasis 4 for the 25-mg dose of oral ...

If the plan pans out, it would be an enormous boon to Eli Lilly and Novo Nordisk. Currently, many health insurance plans, as ...

Obesity medicine specialist Sue Pedersen says the updates also focus on individualizing care and move away from relying on ...

The week-ending August 8 saw 20 companies in the healthcare sector report their quarterly earnings. With the earnings season ...

NEW YORK (AP) — U.S. stocks drifted to a mixed finish on Thursday as President Donald Trump’s tariffs taking effect on dozens ...